Concepts (262)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antioxidants | 22 | 2025 | 443 | 4.940 |
Why?
|
| Oxidative Stress | 23 | 2025 | 1003 | 4.040 |
Why?
|
| Hypertension | 11 | 2022 | 835 | 3.650 |
Why?
|
| Kidney | 15 | 2025 | 372 | 2.780 |
Why?
|
| Rats, Wistar | 19 | 2025 | 283 | 2.540 |
Why?
|
| Sodium Fluoride | 8 | 2022 | 11 | 2.190 |
Why?
|
| Rats | 30 | 2025 | 3735 | 2.150 |
Why?
|
| Neurotoxicity Syndromes | 2 | 2025 | 38 | 1.760 |
Why?
|
| Antihypertensive Agents | 6 | 2020 | 287 | 1.740 |
Why?
|
| Blood Pressure | 11 | 2025 | 666 | 1.700 |
Why?
|
| Luteolin | 4 | 2022 | 10 | 1.640 |
Why?
|
| Endothelin-1 | 9 | 2007 | 57 | 1.500 |
Why?
|
| Animals | 55 | 2025 | 16992 | 1.440 |
Why?
|
| NF-E2-Related Factor 2 | 3 | 2021 | 92 | 1.360 |
Why?
|
| Heart | 5 | 2025 | 184 | 1.360 |
Why?
|
| Flavanones | 5 | 2025 | 15 | 1.330 |
Why?
|
| Vasodilation | 8 | 2016 | 64 | 1.190 |
Why?
|
| Plant Extracts | 5 | 2023 | 302 | 1.140 |
Why?
|
| Azadirachta | 2 | 2018 | 3 | 1.100 |
Why?
|
| Gallic Acid | 2 | 2018 | 11 | 1.080 |
Why?
|
| Endothelium, Vascular | 5 | 2012 | 263 | 1.080 |
Why?
|
| Cobalt | 3 | 2025 | 29 | 1.000 |
Why?
|
| Protective Agents | 4 | 2018 | 26 | 0.950 |
Why?
|
| Silymarin | 1 | 2025 | 3 | 0.920 |
Why?
|
| Diazinon | 1 | 2025 | 3 | 0.910 |
Why?
|
| Apigenin | 1 | 2025 | 14 | 0.910 |
Why?
|
| Catechin | 1 | 2025 | 39 | 0.880 |
Why?
|
| Insecticides | 1 | 2025 | 54 | 0.870 |
Why?
|
| Clofibrate | 3 | 2021 | 12 | 0.840 |
Why?
|
| Signal Transduction | 7 | 2020 | 2157 | 0.830 |
Why?
|
| Memory | 1 | 2025 | 174 | 0.820 |
Why?
|
| Learning | 1 | 2025 | 161 | 0.820 |
Why?
|
| Male | 28 | 2025 | 23409 | 0.800 |
Why?
|
| Kidney Diseases | 2 | 2022 | 172 | 0.800 |
Why?
|
| Cerebrovascular Circulation | 6 | 2002 | 70 | 0.800 |
Why?
|
| Lisinopril | 1 | 2022 | 4 | 0.780 |
Why?
|
| Rutin | 2 | 2020 | 3 | 0.750 |
Why?
|
| Vasodilator Agents | 7 | 2012 | 55 | 0.750 |
Why?
|
| Neuroprotective Agents | 1 | 2025 | 269 | 0.730 |
Why?
|
| PPAR alpha | 3 | 2021 | 42 | 0.720 |
Why?
|
| Nitric Oxide | 7 | 2022 | 386 | 0.720 |
Why?
|
| Receptors, Mineralocorticoid | 4 | 2022 | 15 | 0.710 |
Why?
|
| Apoptosis | 2 | 2020 | 1568 | 0.690 |
Why?
|
| Ramipril | 1 | 2020 | 4 | 0.680 |
Why?
|
| Sodium Compounds | 2 | 2017 | 11 | 0.660 |
Why?
|
| Protein Kinase C | 4 | 2010 | 124 | 0.660 |
Why?
|
| NF-kappa B | 3 | 2020 | 358 | 0.650 |
Why?
|
| Doxorubicin | 2 | 2018 | 97 | 0.650 |
Why?
|
| Dental Caries | 1 | 2021 | 57 | 0.650 |
Why?
|
| Up-Regulation | 2 | 2025 | 536 | 0.640 |
Why?
|
| Dietary Supplements | 2 | 2022 | 213 | 0.630 |
Why?
|
| Arsenites | 2 | 2017 | 54 | 0.630 |
Why?
|
| Hematoma | 5 | 1997 | 15 | 0.620 |
Why?
|
| MAP Kinase Signaling System | 2 | 2018 | 196 | 0.610 |
Why?
|
| Inflammation Mediators | 1 | 2020 | 140 | 0.600 |
Why?
|
| Aorta | 3 | 2012 | 198 | 0.600 |
Why?
|
| Vasoconstrictor Agents | 4 | 2005 | 39 | 0.590 |
Why?
|
| Chickens | 3 | 2025 | 161 | 0.570 |
Why?
|
| Quercetin | 1 | 2018 | 46 | 0.550 |
Why?
|
| Lipid Peroxidation | 1 | 2018 | 140 | 0.550 |
Why?
|
| Sodium Chloride, Dietary | 2 | 2016 | 39 | 0.540 |
Why?
|
| Arsenic Poisoning | 1 | 2017 | 6 | 0.540 |
Why?
|
| Vitamin E | 1 | 2017 | 62 | 0.520 |
Why?
|
| Hindlimb | 2 | 2016 | 32 | 0.520 |
Why?
|
| Brain | 10 | 2025 | 1472 | 0.510 |
Why?
|
| Vasoconstriction | 8 | 2016 | 42 | 0.500 |
Why?
|
| Cariostatic Agents | 1 | 2016 | 4 | 0.500 |
Why?
|
| Orchiectomy | 1 | 2016 | 37 | 0.500 |
Why?
|
| Vascular Resistance | 1 | 2016 | 36 | 0.500 |
Why?
|
| Superoxide Dismutase | 4 | 2018 | 158 | 0.460 |
Why?
|
| Testosterone | 1 | 2016 | 211 | 0.460 |
Why?
|
| Cell Adhesion Molecules | 3 | 2020 | 83 | 0.450 |
Why?
|
| Reactive Oxygen Species | 2 | 2016 | 532 | 0.450 |
Why?
|
| Phenylephrine | 3 | 2016 | 34 | 0.450 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2017 | 299 | 0.440 |
Why?
|
| Glutathione | 4 | 2018 | 171 | 0.430 |
Why?
|
| Swine | 12 | 2006 | 212 | 0.430 |
Why?
|
| Liver | 4 | 2023 | 511 | 0.410 |
Why?
|
| Myocardium | 3 | 2025 | 263 | 0.410 |
Why?
|
| Malondialdehyde | 3 | 2018 | 42 | 0.400 |
Why?
|
| Pia Mater | 4 | 2002 | 5 | 0.360 |
Why?
|
| Bradykinin | 2 | 2012 | 25 | 0.360 |
Why?
|
| NG-Nitroarginine Methyl Ester | 5 | 2023 | 36 | 0.360 |
Why?
|
| Disease Models, Animal | 3 | 2025 | 1596 | 0.350 |
Why?
|
| Serotonin | 3 | 2002 | 123 | 0.340 |
Why?
|
| Catalase | 3 | 2018 | 110 | 0.330 |
Why?
|
| Animals, Newborn | 8 | 2005 | 352 | 0.330 |
Why?
|
| Glycerol | 2 | 2020 | 34 | 0.330 |
Why?
|
| Peptidyl-Dipeptidase A | 2 | 2020 | 35 | 0.330 |
Why?
|
| Dose-Response Relationship, Drug | 8 | 2016 | 1124 | 0.320 |
Why?
|
| Cerebral Cortex | 2 | 2010 | 306 | 0.320 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2012 | 131 | 0.320 |
Why?
|
| Nitroprusside | 4 | 2016 | 14 | 0.310 |
Why?
|
| Acetylcholine | 2 | 2012 | 77 | 0.300 |
Why?
|
| Arginine | 2 | 2022 | 75 | 0.280 |
Why?
|
| Clonidine | 5 | 2002 | 50 | 0.270 |
Why?
|
| Chlorides | 2 | 2025 | 59 | 0.270 |
Why?
|
| Glutathione Peroxidase | 2 | 2018 | 112 | 0.270 |
Why?
|
| Trypanosoma cruzi | 3 | 1994 | 157 | 0.270 |
Why?
|
| Electrocardiography | 2 | 2018 | 185 | 0.260 |
Why?
|
| Gene Expression Regulation | 2 | 2018 | 1070 | 0.260 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2016 | 1766 | 0.240 |
Why?
|
| Angiotensins | 2 | 2022 | 10 | 0.240 |
Why?
|
| Cerebral Hemorrhage | 2 | 1997 | 104 | 0.240 |
Why?
|
| Yohimbine | 5 | 1991 | 24 | 0.230 |
Why?
|
| Aluminum Compounds | 1 | 2025 | 10 | 0.230 |
Why?
|
| Dioxanes | 4 | 1991 | 11 | 0.230 |
Why?
|
| Mammals | 2 | 2022 | 112 | 0.230 |
Why?
|
| Cyclooxygenase 2 | 1 | 2005 | 107 | 0.220 |
Why?
|
| Dioxins | 3 | 1990 | 8 | 0.220 |
Why?
|
| Maze Learning | 1 | 2025 | 113 | 0.220 |
Why?
|
| Endocrine Disruptors | 1 | 2025 | 44 | 0.220 |
Why?
|
| Free Radicals | 1 | 2004 | 70 | 0.220 |
Why?
|
| Cerebral Arteries | 3 | 2000 | 24 | 0.220 |
Why?
|
| Subarachnoid Hemorrhage | 2 | 1997 | 92 | 0.210 |
Why?
|
| Oxidation-Reduction | 1 | 2025 | 457 | 0.200 |
Why?
|
| Isoproterenol | 4 | 2012 | 39 | 0.200 |
Why?
|
| Immunohistochemistry | 3 | 2025 | 934 | 0.200 |
Why?
|
| Lysophospholipids | 3 | 2000 | 20 | 0.200 |
Why?
|
| Organometallic Compounds | 1 | 2023 | 71 | 0.200 |
Why?
|
| Endothelial Cells | 1 | 2006 | 329 | 0.200 |
Why?
|
| Anacardium | 1 | 2023 | 2 | 0.200 |
Why?
|
| Cardiovascular Agents | 2 | 2002 | 24 | 0.200 |
Why?
|
| Glycine | 1 | 2023 | 47 | 0.190 |
Why?
|
| Sympatholytics | 1 | 2002 | 13 | 0.190 |
Why?
|
| Calcium Channels, L-Type | 1 | 2002 | 20 | 0.190 |
Why?
|
| Arterioles | 6 | 2002 | 19 | 0.190 |
Why?
|
| Receptors, Angiotensin | 1 | 2022 | 13 | 0.190 |
Why?
|
| Diclofenac | 1 | 2022 | 5 | 0.190 |
Why?
|
| Random Allocation | 2 | 2025 | 147 | 0.190 |
Why?
|
| Cells, Cultured | 5 | 2010 | 1621 | 0.190 |
Why?
|
| Microcirculation | 4 | 2006 | 40 | 0.180 |
Why?
|
| Down-Regulation | 2 | 2022 | 456 | 0.180 |
Why?
|
| Endothelins | 3 | 1997 | 7 | 0.180 |
Why?
|
| Potassium Dichromate | 1 | 2021 | 3 | 0.180 |
Why?
|
| Prostaglandins | 3 | 1997 | 23 | 0.180 |
Why?
|
| Lead | 1 | 2022 | 100 | 0.180 |
Why?
|
| Peroxidase | 2 | 2018 | 57 | 0.170 |
Why?
|
| Heart Rate | 3 | 2018 | 266 | 0.170 |
Why?
|
| Caesalpinia | 1 | 2020 | 1 | 0.170 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2002 | 192 | 0.160 |
Why?
|
| Angiotensin II | 1 | 2020 | 102 | 0.160 |
Why?
|
| Calcium | 3 | 2002 | 491 | 0.160 |
Why?
|
| Leukotriene C4 | 2 | 2000 | 6 | 0.160 |
Why?
|
| Cocaine | 1 | 2002 | 251 | 0.150 |
Why?
|
| Cyclic AMP | 5 | 2003 | 127 | 0.150 |
Why?
|
| Protein Carbonylation | 1 | 2018 | 8 | 0.150 |
Why?
|
| Abrus | 1 | 2018 | 1 | 0.150 |
Why?
|
| Glutathione Reductase | 1 | 2018 | 19 | 0.150 |
Why?
|
| Troponin I | 1 | 2018 | 18 | 0.150 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2020 | 187 | 0.140 |
Why?
|
| Drug Administration Schedule | 1 | 2018 | 153 | 0.140 |
Why?
|
| Xanthine Oxidase | 1 | 2018 | 9 | 0.140 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2018 | 57 | 0.140 |
Why?
|
| PPAR gamma | 1 | 2018 | 55 | 0.140 |
Why?
|
| Creatine Kinase | 1 | 2018 | 22 | 0.140 |
Why?
|
| Nitric Oxide Synthase Type III | 2 | 2010 | 75 | 0.140 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2018 | 64 | 0.140 |
Why?
|
| Micronuclei, Chromosome-Defective | 1 | 2017 | 7 | 0.130 |
Why?
|
| Alanine Transaminase | 1 | 2017 | 27 | 0.130 |
Why?
|
| Injections, Intraperitoneal | 1 | 2017 | 60 | 0.130 |
Why?
|
| Naphthalenes | 2 | 2010 | 38 | 0.130 |
Why?
|
| Neutrophil Infiltration | 1 | 2017 | 28 | 0.130 |
Why?
|
| Bilirubin | 1 | 2017 | 18 | 0.130 |
Why?
|
| Alkaline Phosphatase | 1 | 2017 | 54 | 0.130 |
Why?
|
| Humans | 5 | 2022 | 43102 | 0.130 |
Why?
|
| Kidney Cortex | 1 | 2016 | 8 | 0.130 |
Why?
|
| Nitrites | 1 | 2016 | 55 | 0.120 |
Why?
|
| Drinking | 1 | 2016 | 37 | 0.120 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 146 | 0.120 |
Why?
|
| Ascorbic Acid | 2 | 2007 | 74 | 0.120 |
Why?
|
| Receptors, Adrenergic, alpha | 3 | 1992 | 17 | 0.120 |
Why?
|
| Brain Diseases | 1 | 1995 | 31 | 0.110 |
Why?
|
| Ionomycin | 1 | 1994 | 11 | 0.110 |
Why?
|
| Body Weight | 1 | 2016 | 429 | 0.110 |
Why?
|
| Calmodulin | 1 | 1994 | 47 | 0.110 |
Why?
|
| Adenosylmethionine Decarboxylase | 1 | 1993 | 1 | 0.100 |
Why?
|
| Deoxyadenosines | 1 | 1993 | 8 | 0.100 |
Why?
|
| 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 2 | 2005 | 9 | 0.100 |
Why?
|
| Neurons | 1 | 2020 | 1263 | 0.100 |
Why?
|
| Drug Combinations | 2 | 2005 | 104 | 0.090 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2010 | 43 | 0.080 |
Why?
|
| Sus scrofa | 1 | 2010 | 19 | 0.080 |
Why?
|
| Microvessels | 1 | 2010 | 31 | 0.080 |
Why?
|
| Blood Glucose | 1 | 2012 | 389 | 0.080 |
Why?
|
| Rabbits | 6 | 1992 | 278 | 0.070 |
Why?
|
| Enzyme Inhibitors | 1 | 2010 | 458 | 0.070 |
Why?
|
| Muscle Contraction | 1 | 2007 | 67 | 0.070 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2007 | 140 | 0.060 |
Why?
|
| Idazoxan | 4 | 1991 | 10 | 0.060 |
Why?
|
| Indomethacin | 2 | 1997 | 25 | 0.060 |
Why?
|
| Arachidonic Acid | 1 | 2005 | 35 | 0.060 |
Why?
|
| Radioimmunoassay | 1 | 2005 | 70 | 0.060 |
Why?
|
| Blotting, Northern | 1 | 2005 | 150 | 0.060 |
Why?
|
| Dinoprostone | 1 | 2005 | 64 | 0.060 |
Why?
|
| Drug Interactions | 1 | 2005 | 150 | 0.060 |
Why?
|
| Xanthine | 1 | 2004 | 4 | 0.060 |
Why?
|
| Time Factors | 3 | 1996 | 1857 | 0.050 |
Why?
|
| Testis | 1 | 2025 | 207 | 0.050 |
Why?
|
| Analysis of Variance | 1 | 2004 | 575 | 0.050 |
Why?
|
| Necrosis | 1 | 2023 | 54 | 0.050 |
Why?
|
| Glucose | 1 | 2004 | 244 | 0.050 |
Why?
|
| Acetylcholinesterase | 1 | 2023 | 56 | 0.050 |
Why?
|
| Osmolar Concentration | 1 | 2002 | 52 | 0.050 |
Why?
|
| Intracellular Membranes | 1 | 2002 | 36 | 0.050 |
Why?
|
| Proteins | 1 | 2005 | 382 | 0.050 |
Why?
|
| Memory Disorders | 1 | 2023 | 77 | 0.050 |
Why?
|
| Autonomic Nervous System | 1 | 2002 | 39 | 0.050 |
Why?
|
| Fetus | 1 | 2002 | 101 | 0.050 |
Why?
|
| Birth Weight | 1 | 2002 | 95 | 0.050 |
Why?
|
| Calcium Signaling | 1 | 2002 | 107 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2022 | 200 | 0.040 |
Why?
|
| Binding Sites | 4 | 1992 | 671 | 0.040 |
Why?
|
| Cell Line | 2 | 1994 | 1410 | 0.040 |
Why?
|
| Plant Bark | 1 | 2018 | 8 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2022 | 561 | 0.040 |
Why?
|
| Gentamicins | 1 | 2018 | 10 | 0.040 |
Why?
|
| Creatinine | 1 | 2018 | 102 | 0.040 |
Why?
|
| Inflammation | 1 | 2023 | 758 | 0.030 |
Why?
|
| Iloprost | 1 | 1996 | 1 | 0.030 |
Why?
|
| Pregnancy | 1 | 2002 | 1772 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 1997 | 127 | 0.030 |
Why?
|
| Blood Vessels | 1 | 1996 | 36 | 0.030 |
Why?
|
| Peptides, Cyclic | 1 | 1996 | 29 | 0.030 |
Why?
|
| Drug Synergism | 1 | 1997 | 195 | 0.030 |
Why?
|
| Leukotrienes | 1 | 1994 | 4 | 0.030 |
Why?
|
| Egtazic Acid | 1 | 1994 | 13 | 0.030 |
Why?
|
| Aminoquinolines | 1 | 1994 | 17 | 0.030 |
Why?
|
| Indicators and Reagents | 1 | 1994 | 61 | 0.030 |
Why?
|
| Norepinephrine | 2 | 1991 | 97 | 0.030 |
Why?
|
| Fluorescent Dyes | 1 | 1994 | 182 | 0.020 |
Why?
|
| Eflornithine | 1 | 1992 | 18 | 0.020 |
Why?
|
| Agmatine | 1 | 1992 | 17 | 0.020 |
Why?
|
| Kinetics | 2 | 1991 | 695 | 0.020 |
Why?
|
| Cell Division | 1 | 1992 | 311 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 1992 | 146 | 0.020 |
Why?
|
| Imidazoles | 1 | 1991 | 142 | 0.020 |
Why?
|
| Amitriptyline | 1 | 1990 | 9 | 0.020 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 1990 | 32 | 0.020 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 1990 | 29 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 1993 | 1081 | 0.020 |
Why?
|
| Brain Chemistry | 1 | 1990 | 141 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 1988 | 67 | 0.020 |
Why?
|
| Aorta, Thoracic | 1 | 2003 | 31 | 0.010 |
Why?
|
| Female | 1 | 2002 | 24698 | 0.010 |
Why?
|
| Guanabenz | 2 | 1992 | 3 | 0.010 |
Why?
|
| Oxazoles | 2 | 1992 | 19 | 0.010 |
Why?
|
| Binding, Competitive | 2 | 1991 | 109 | 0.010 |
Why?
|
| Blood Physiological Phenomena | 1 | 1995 | 6 | 0.010 |
Why?
|
| Injections, Spinal | 1 | 1995 | 8 | 0.010 |
Why?
|
| Virulence Factors, Bordetella | 1 | 1995 | 5 | 0.010 |
Why?
|
| Pertussis Toxin | 1 | 1995 | 25 | 0.010 |
Why?
|
| Carbon Dioxide | 1 | 1995 | 86 | 0.010 |
Why?
|
| Cisterna Magna | 1 | 1992 | 2 | 0.010 |
Why?
|
| Infusion Pumps | 1 | 1992 | 4 | 0.010 |
Why?
|
| Osmosis | 1 | 1992 | 9 | 0.010 |
Why?
|
| Radioligand Assay | 1 | 1992 | 65 | 0.010 |
Why?
|
| Injections | 1 | 1992 | 42 | 0.010 |
Why?
|
| Parasympathetic Nervous System | 1 | 1991 | 8 | 0.010 |
Why?
|
| Sympathetic Nervous System | 1 | 1991 | 57 | 0.010 |
Why?
|
| Hemodynamics | 1 | 1990 | 100 | 0.000 |
Why?
|
| Central Nervous System | 1 | 1990 | 152 | 0.000 |
Why?
|